fda warning letters glp-1 september 2025 news issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Drug Recalls and Warnings:
Description
Poston L, Caleyachetty R, Cnattingius S, Corvaln C, Uauy R, Herring S, Gillman MW

Teotia emphasizes that this procedure restores contour

Earlier fatigue, reduced power output, and that heavy, sluggish feeling during training

These medications include semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro)

Ripa, R

M., Liu, H., & Qu, S
